Inpatient Satisfaction With Information About Warfarin Provided In A Large UK-based Hospital Trust | 13264
Clinical Pharmacology & Biopharmaceutics
Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Evidence indicates that dissatisfaction with information received about medicines contributes to reduced medicines adherence
amongst patients. The primary objective of this study was to determine the degree to which inpatients were satisfied with the
information they received about warfarin during their hospital stay in a large UK-based Trust. Patient satisfaction was measured
using an adapted (14-item) Satisfaction with Information about Medicines Scale (SIMS). Questionnaires were distributed to
inpatients, newly started on warfarin that had been counselled over a three week period. The questionnaire asks respondents to
rate information provided about 14 different aspects of warfarin. Each question has five response options ranging from ?Too much?
to ?none needed?. The optimum response is ?About right?. Levels of patient satisfaction were classified based on the number of times
participants responded that the level of information provided was ?About right?: 12 or more items - very satisfied; 10 or 11 items
- satisfied; nine or less items - dissatisfied. Twenty-four questionnaires were completed. Sixty three percent of respondents were
very satisfied; 17% were satisfied and 21% dissatisfied. Areas where patients most commonly felt they had not been given sufficient
information included, how long it would take warfarin to act and what to do if they experienced unwanted side effects. Overall the
majority of patients were satisfied with information provided about warfarin. The results of this small study highlighted specific
areas where communication of information can be improved to address and reduce patients? concerns about warfarin therapy.
Future work should incorporate novel anticoagulants.
Frances Akinwunmi, first started working in anticoagulation in 2002 when she commenced a Ph.D. which explored the redesign of anticoagulation
services in different care settings. Over the years, Frances has delivered a variety of anticoagulation services in secondary and primary care. As
part of her current role she provides leadership through promoting clinical governance as it pertains to anticoagulation. Frances is a member of the
UKCPA Haemostasis Anticoagulation and Thrombosis committee and a board member of the multidisciplinary Anticoagulation in Practice Society,
contributing to the educational and conference activities of both.
Aside from anticoagulation, Frances has an interest in medicines adherence.
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals